Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)
NCT00690612
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
candesartan cilexetil
Sponsor
AstraZeneca